Quelamycin, a new derivative of adriamycin with several possible therapeutic advantages.
D000284:Administration, Oral; D000818:Animals; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004562:Electrocardiography; D005290:Ferric Compounds / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000378:metabolism; D008297:Male; D051379:Mice; D009206:Myocardium / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D004273:DNA, Neoplasm; D005290:Ferric Compounds; C018376:quelamycin; D004317:Doxorubicin; D000254:Sodium-Potassium-Exchanging ATPase